Literature DB >> 31809323

Novel Clinical Trial Designs to Improve the Efficiency of Research.

Daniel I Sessler1, Paul S Myles.   

Abstract

Large randomized trials provide the highest level of clinical evidence. However, enrolling large numbers of randomized patients across numerous study sites is expensive and often takes years. There will never be enough conventional clinical trials to address the important questions in medicine. Efficient alternatives to conventional randomized trials that preserve protections against bias and confounding are thus of considerable interest. A common feature of novel trial designs is that they are pragmatic and facilitate enrollment of large numbers of patients at modest cost. This article presents trial designs including cluster designs, real-time automated enrollment, and practitioner-preference approaches. Then various adaptive designs that improve trial efficiency are presented. And finally, the article discusses the advantages of embedding randomized trials within registries.

Entities:  

Year:  2020        PMID: 31809323     DOI: 10.1097/ALN.0000000000002989

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  2 in total

Review 1.  Idiopathic pulmonary fibrosis: Disease mechanisms and drug development.

Authors:  Paolo Spagnolo; Jonathan A Kropski; Mark G Jones; Joyce S Lee; Giulio Rossi; Theodoros Karampitsakos; Toby M Maher; Argyrios Tzouvelekis; Christopher J Ryerson
Journal:  Pharmacol Ther       Date:  2020-12-24       Impact factor: 13.400

2.  Protocol for SYNchronising Exercises, Remedies in GaIt and Cognition at Home (SYNERGIC@Home): feasibility of a home-based double-blind randomised controlled trial to improve gait and cognition in individuals at risk for dementia.

Authors:  Chris McGibbon; Pam Jarrett; Grant Handrigan; Danielle Bouchard; Carole C Tranchant; Andrew M Sexton; Linda Yetman; Bryn Robinson; Stephanie Crapoulet; Ludivine Chamard-Witkowski; Teresa Liu-Ambrose; Laura Elizabeth Middleton; Quincy J Almeida; Louis Bherer; Andrew Lim; Mark Speechley; Nellie Kamkar; Manuel Montero Odasso
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.